Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz

August 30, 2024
Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared HolzUpside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz
Share This

Jared Holz, Mizuho, joins ‘Fast Money’ to talk opportunities in pharma investing following approval of Emergent Bio’s Mpox vaccine.


 

Latest Mizuho News

See all news
Mizuho’s Jared Holz on Moderna’s leg up on new cancer shot data

Mizuho’s Jared Holz on Moderna’s leg up on new cancer shot data

August 19, 2026
Nvidia holders to focus on AI data, Mizuho's Rakesh says

Nvidia holders to focus on AI data, Mizuho's Rakesh says

August 26, 2026
Mizuho Retains “Outstanding” Community Reinvestment Act Ratings

Mizuho Retains “Outstanding” Community Reinvestment Act Ratings

August 10, 2026

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue